CV_Henry Skinner
PDF Upload
Our CEO, Dr. Henry Skinner joins the Fund from Tekla Capital Management,
where he was Senior Vice President, Venture. Prior to joining Tekla, Dr. Skinner
Served as Deputy Head and Managing Director of Novartis Venture Fund. In
addition, Dr. Skinner has been CEO of SelectX Pharmaceuticals and
NeoGenesis Pharmaceuticals and has held positions in Business Development
for Novartis Institutes for Biomedical Research, Pfizer, Pharmacia, Pharmacia &
Upjohn and Lexicon Genetics. Dr. Skinner was a postdoctoral fellow at Baylor
College of Medicine in the department of Human and Molecular Genetics,
earned his Ph.D. in Microbiology and M.S. in Biochemistry from the University of
Illinois and M.S. and B.S. in Biology/Biotechnology from Worcester Polytechnic
Institute.